Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5842-5848

  Wang, Xiao Zhuo ^a   Beebe, James R ^a   Pwiti, Leah ^a   Bielawska, Alicja ^a   Smyth, Miriam J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CERAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CARBOXYLIC ACIDS; CERAMIDES; DNA FRAGMENTATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; FUMONISINS; HUMANS; MALE; MOLECULAR WEIGHT; NEOPLASM PROTEINS; OXIDOREDUCTASES; PROSTATIC NEOPLASMS; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033571159     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Hannun, Y. A. Apoptosis and the dilemma of cancer chemotherapy. Blood, 89: 1845-1853, 1997.
2. Teicher, B. A., Kakeji, Y., Ara, G., Herbst, R. S., and Northey, D. Prostate carcinoma response to cytotoxic therapy: in vivo resistance. In Vivo, 11: 453-462, 1997.
3. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics. CA Cancer J. Clin., 45: 8-30, 1995.
4. Parker, S., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 47: 5-27, 1997.
5. Murphy, G. P., Natarasan, N., Pontes, J. E., Schmitz, R. I., Small, C. R., Schmidt, J. D., and Mettlin, C. The national survey of prostate cancer in the United States by the American College of Surgeons. J. Urol., 127: 928-934, 1982.
6. Coffey, D. S. Prostate Cancer: an overview of an increasing dilemma. Cancer (Phila.), 71 (Suppl.): 880-890, 1993.
7. Kyprianou, N., Martikainen, P., Davis, L., English, H. F., and Isaacs, J. T. Programmed cell death as a new target for prostalic cancer therapy. Cancer Surv., 11: 265-274, 1991.
8. Kyprianou, N. Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer. World J. Urol., 12: 299-303, 1994.
9. Vaux, D. L., Haeker, G., and Strasser, A. An evolutionary perspective on apoptosis. Cell. 76: 777-779, 1994.
10. Jarvis, W. D., Grant, S., and Kolesnick, R. N. Ceramide and the induction of apoptosis. Clin. Cancer Res., 2: 1-6, 1996.
11. Hannun, Y. A. Functions of ceramide in coordinating cellular responses to stress. Science (Washington DC), 274: 1855-1859, 1996.
12. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. Programmed cell death induced by ceramide. Science (Washington DC), 259: 1769-1771, 1993.
13. Hannun Y. A., and Obeid, L. M. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci., 20: 73-77, 1995.
14. Jayadev, S., Liu, B., Bielawska, A. E., Lee, J. Y., Nazaire, F., Pushkareva, M. Y., Obeid, L. M., and Hannun, Y. A. Role for ceramide in cell cycle arrest. J. Biol. Chem., 270: 2047-2052, 1995.
15. 2 production and sphingomyelin metabolism: evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J. Biol. Chem., 267; 20044-20050, 1992.
16. Machleidt, T., Wiegmann, K., Henkel, T., Schutze, S., Baeuerle, P., and Kronke, M. Sphingomyelinase activates proteolytic IκB-α degradation in a cell-free system. J. Biol. Chem., 269: 13760-13765, 1994.
17. Dobrowsky, R. T., Werner, M. H., Castellino, A. M., Chao, M. V., and Hannun, Y. A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science (Washington DC), 265: 1596-1599, 1994.
18. Quintans, J., Kilkus, J., McShan, C. L., Gottschalk, A. R., and Dawson, G. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin cortico-steroids and irradiation. Biochem. Biophys. Res. Commun., 202: 710-714, 1994.
19. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R. A, Yonehara, S., Hannun, Y. A., and Seldin, M. F. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA, 92: 8443-8447, 1995.
20. Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishioka, W., Brunner, T., Baier, G., Baier-Bitterlich, G.,. Byrd, C., Lang, F., Kolesnick, R., Altman, A., and Green, D. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity, 2: 341-351, 1995.
21. Haimovitz-Friedman, A., Kan, C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180: 525-535, 1994.
22. Strum, J. C., Small, G. W., Pauig, S. B., and Daniel, L. W. 1-β-D-Arabinofuranosyl-cytosine stimulates ceramide and diglyceride formation in HL-60 cells. J. Biol. Chem., 269; 15493-15497, 1994.
23. Zhang, J., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun, Y. A. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. USA, 93: 5325-5328, 1996.
24. Smyth, M. J., Perry, D. K., Zhang, J., Poirier, G. G., Hannun, Y. A., and Obeid, L. M. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem. J., 316: 25-28, 1996.
25. Perry, D. K., Smyth, M. J., Wang, H-G., Reed, J. C., Poirier, G. G., Obeid, L. M., and Hannun, Y. A. Bcl-2 acts upstream of the PARP protease and prevents its activation. Cell Death Differ., 4: 29-33, 1997.
26. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72; 248-254, 1976.
27. Wetsel, W. C., Kahn, W. A., Merchenthaler, I., Rivera, H., Halpern, A. E., Phung, H. M., Negro-Vilar, A., and Hannun, Y. A. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J. Cell. Biol., 117: 121-133, 1992.
28. Shah, G. M., Poirier, D., Duchaine, C., Brochu, G., Desnoyers, S., Lagueux, J., Verreault, A., Hoflack, J. C., Kirkland, J. B., and Poirier G. G. Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo. Anal. Biochem., 227: 1-13, 1995.
29. Preston, G. A., Barrett, S. C., Biermann, J. A., and Murphy, E. Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. Cancer Res., 57: 537-542, 1997.
30. Bligh, E. G., and Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Phys., 37: 911-917, 1959.
31. Okazaki, T., Bielawska, A., Bell, R. M., and Hannun, Y. A. Role of ceramide as a lipid mediator of 1α,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem., 265: 15823-15831, 1990.
32. Preiss, J., Loomis, C. R., Bishop, W. R., Stein, R., Niedel, J. E., and Bell, R. M. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem., 261: 8597-8600, 1986.
33. Van Veldhoven, P. P., Bishop, W. R., Yurivich, D. A., and Bell, R. M. Ceramide quantitation: evaluation of a mixed micellar assay using E. coli diacylglycerol kinase. Biochem. Mol. Biol. Int., 36: 21-30, 1995.
34. Lee, E., Miura, M., Yoshinari, M., Iwai, H., and Kariya, K. Selective inhibition of dexamethasone-induced apoptosis in rat thymocytes by herbimycin A. Biochem. Biophys. Res. Commun., 202: 128-134, 1994.
35. Thomas, A., El-Rouby, S., Reed, J. C., Krajewski, S., Silber, R., Potmesil, M., and Newcomb, E. W. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12: 1055-1062, 1996.
36. Burkle, A., Grube, K., and Kupper, J. Poly (ADP-ribosyl)ation: its role in inducible DNA amplification and its correlation with the longevity of mammalian species. Exp. Clin. Immunogenet., 9: 230-240, 1992.
37. Kaufman, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
38. Merrill, A. H., Jr., and Jones, D. D. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim. Biophys. Acta, 1044: 1-12, 1990.
39. Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T., and Merrill, A. H., Jr. Inhibition of sphingolipid biosynthesis by fumonisins. J. Biol. Chem., 266: 14486-14490, 1991.
40. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell, 82: 405-411, 1995.
41. Suzuki, A., Iwasaki, M., Kato, M., and Wagai, N. Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. Exp. Cell Res., 233: 41-47, 1997.
42. Garzotto, M., White-Jones, M., Jiang, Y., Ehleiter, D., Liao, W-C., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. 12-0-Tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res., 58: 2260-2264, 1998.
43. 2+ sensitive endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro. Biochim. Biophys. Acta, 1266: 135-142, 1995.
44. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
45. Tang, D. G., and Porter, A. T. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate, 32: 284-293, 1997.
46. Marcelli, M., Cunningham, G. R., Haidacher, J., Padayatty, S. J., Sturgis, L., Kagan, C., and Denner, L. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res., 58: 76-83, 1998.
47. Herrmann, J. L., Menter, D. G., Beham, A., von Eschenbach, A., and McDonnell, T. J. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp. Cell Res., 234: 442-451, 1997.
48. Arah, I. N., Song, K., Seth, P., Cowan, K. H., and Sinha, B. K. Role of wild-type p53 in the enhancement of camptothecin cytotoxicity against human prostate tumor cells. Anticancer Res., 18: 1845-1850, 1998.
49. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
50. Young, C. Y., Murtha, P. E., and Zhang, J. Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol. Res., 6: 203-210, 1994.
51. Hannun, Y. A. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem., 269: 3125-3128, 1994.
52. Smyth, M. J., Obeid, L. M., and Hannun, Y. A. Ceramide: a novel lipid mediator of apoptosis. Adv. Pharmacol., 41: 133-154, 1997.
53. Sinha, B. K. Topoisomerase inhibitors: a review of their therapeutic potential in cancer. Drugs, 49: 11-19, 1995.
54. Kaufmann, S. H. Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim. Biophys. Acta, 1400: 195-211, 1998.
55. Dbaibo, G. S., Pushkareva, M. Y., Rachid, R. A., Alter, N., Smyth, M. J., and Obeid, L. M. p53-dependent ceramide response to genotoxic stress. J. Clin. Investig., 102: 329-339. 1998.
56. Thornberry, N. A. The caspase family of cysteine proteases. Br. Med. Bull., 53: 478-490, 1996.
57. Lievano, G., Mirochnik, Y., Rubenstein, M., Shaw, M., and Guinan, P. Antitumor effect of CPT-11, a new derivative of camptothecin, against human prostate cancer (PC-3) in vitro and prostate rat tumor (AT-3) in vivo. Exp. Clin. Pharmacol., 18: 659-662, 1996.
58. Carducci, M. A., DeWeese, T. L., Nelson, W. G., Simons, J. W., Sinibaldi, V., and Eisenberger, M. A. Prostate cancer treatment strategies based on tumor-specific biological principles: future directions. Semin. Oncol., 6: 56-62, 1996.